Literature DB >> 17596609

Teratogenicity of SSRIs--serious concern or much ado about little?

Michael F Greene.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17596609     DOI： 10.1056/NEJMe078079

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

2.  Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.

Authors:  David M Haas; Mary F Hebert; Offie P Soldin; David A Flockhart; Parvaz Madadi; James J Nocon; Christina D Chambers; Gary D Hankins; Shannon Clark; Katherine L Wisner; Lang Li; Jamie L Renbarger; Lee A Learman
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

3.  Discrepancy in Insulin Regulation between Gestational Diabetes Mellitus (GDM) Platelets and Placenta.

Authors:  Yicong Li; Anthonya Cooper; Imelda N Odibo; Asli Ahmed; Pamela Murphy; Ruston Koonce; Nafisa K Dajani; Curtis L Lowery; Drucilla J Roberts; Luc Maroteaux; Fusun Kilic
Journal:  J Biol Chem       Date:  2016-02-26       Impact factor: 5.157

4.  Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.

Authors:  Holly J Engelstad; Robert D Roghair; Chadi A Calarge; Tarah T Colaizy; Scott Stuart; Sarah E Haskell
Journal:  Neonatology       Date:  2013-12-18       Impact factor: 4.035

Review 5.  Depression During Pregnancy and Postpartum.

Authors:  Madeleine Becker; Tal Weinberger; Ann Chandy; Sarah Schmukler
Journal:  Curr Psychiatry Rep       Date:  2016-03       Impact factor: 5.285

Review 6.  Antidepressant use in pregnant and postpartum women.

Authors:  Kimberly A Yonkers; Katherine A Blackwell; Janis Glover; Ariadna Forray
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

7.  Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.

Authors:  Katherine L Wisner; Dorothy K Y Sit; Barbara H Hanusa; Eydie L Moses-Kolko; Debra L Bogen; Diane F Hunker; James M Perel; Sonya Jones-Ivy; Lisa M Bodnar; Lynn T Singer
Journal:  Am J Psychiatry       Date:  2009-03-16       Impact factor: 18.112

8.  A tale of 2s: optimizing maternal-child health in the context of antenatal maternal depression and antidepressant use.

Authors:  Tim F Oberlander; Katherine L Wisner
Journal:  Can J Psychiatry       Date:  2012-09       Impact factor: 4.356

Review 9.  Safety of selective serotonin reuptake inhibitors in pregnancy.

Authors:  Sura Alwan; Jan M Friedman
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

10.  Impact of neonatal sertraline exposure on the post-myocardial infarction outcomes of adult male mice.

Authors:  Sarah E Haskell; Veronica A Peotta; Benjamin E Reinking; Gregory M Hermann; Robert D Roghair
Journal:  J Cardiovasc Pharmacol       Date:  2013-11       Impact factor: 3.105
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.